A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To compare the efficacy of sustained-release (SR) bupropion to placebo in treating hypoactive sexual desire disorder (HSDD) in ovulating women.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): BJU Int.

Title: BJU international

ISSN (Electronic): 1464-410X

ISSN (Print): 1464-4096

Publication date (Electronic): Sep 2010

Volume: 106

Issue: 6

Affiliations

[1 ] Urology and Nephrology Research Centre, Shahid Modarress Hospital, Shahid Beheshti University, Tehran, Iran. safarinejad@unrc.ir

Article

Publisher Item ID: BJU9208

DOI: 10.1111/j.1464-410X.2010.09208.x

PubMed ID: 20151970

SO-VID: ade2819a-3a5c-45ee-a127-96dd91f5044d

History

Data availability:

Comments

Comment on this article

scite_

Cited by 9

See all cited by